Michel Van Harten News Today : Breaking News, Live Updates & Top Stories | Vimarsana

myTomorrows and brainstrust partner to support patients living with brain cancer

myTomorrows and brainstrust partner to support patients living with brain cancer
pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.

Helen bulbeckMichel van hartenUnited kingdom based

myTomorrows and brainstrust Partner to Support the Brain Cancer Community in Accessing Clinical Trials

myTomorrows and brainstrust Partner to Support the Brain Cancer Community in Accessing Clinical Trials
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNoord hollandBen cromeDennis riedlMichel van hartenHelen bulbeckUnited kingdom basedNew york cityTomorrows media contactMedia contact

myTomorrows Partners with brainstrust to Support Brain Cancer Patients in Accessing Clinical Trials

myTomorrows Partners with brainstrust to Support Brain Cancer Patients in Accessing Clinical Trials
hitconsultant.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hitconsultant.net Daily Mail and Mail on Sunday newspapers.

Michel van hartenShould knowUnited kingdom basedBrain tumor patientsAccessing clinical trials

Michel van Harten, Author at MedCity News

Michel van Harten, Author at MedCity News
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMichel van hartenUniversity of amsterdamDepartment of surgical oncologyMedical degreeLeeuwenhoek hospitalWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup funding

Congenica and myTomorrows team up to improve patient access to precision oncology

A partnership deal between the Dutch digital health company Congenica and clinical trial platform provider myTomorrows will see the companies pooling their technologies to help more patients receive precision oncology treatments.

Michel van hartenOutsourcing pharmaReal world dataAbsolute markets insightsGenome medicalClinical developmentAtient centricityPrecision medicine